Stacy Stein, MD, and co-investigators, research omalizumab to treat oxaliplatin hypersensitivity reactions for patients with gastrointestinal cancers.
Kirsten Dooley, BS, APRN
Advertisement
Articles by Kirsten Dooley, BS, APRN
Advertisement
Latest Updated Articles
A Pilot Study of Omalizumab to Treat Oxaliplatin-Induced Hypersensitivity ReactionPublished: July 18th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
2
Zanzalintinib Combo Improves Survival in Pretreated Metastatic CRC
3
Temab-A Displays Early Efficacy in Locally Advanced/Metastatic PDAC
4
Relacorilant Regimen Improves PFS in Platinum-Resistant Ovarian Cancer
5
